Brain/Spinal Cord Cancers
Radiation Therapy With or Without Temozolomide for Anaplastic Glioma (7880)
Phase III Trial On Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1P/19Q Deleted Anaplastic Glioma: The CATNON Intergroup Trial (RTOG 0834)
Investigator: George Laramore, MD, PhD; Conditions: Brain and Central Nervous System Tumors; Status: Recruiting; Study ID: NCT00626990
Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas
Investigator: Hans-Peter Kiem, MD; Conditions: Brain Cancer; Glioma; Solid Tumors; Status: Recruiting; Study ID: NCT00669669
Phase III Study of Radiation Therapy With or Without Temozolomide For Symptomatic or Progressive Low-Grade Gliomas
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors, Neurotoxicity Syndromes; Status: Recruiting; Study ID: NCT00978458
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation and Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation and Adjuvant Temozolomide Plus Placebo in Patients with Newly Diagnosed Glioblastoma
Investigator: George Laramore, MD; Conditions: Brain and Central Nervous System Tumors; Status: Closed; Study ID: NCT01062425
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244
Investigator: Maciej Mrugala, MD, PhD; Conditions: Astrocytomas; Brain Cancer; Central Nervous System (CNS); Glioblastoma Multiforme; Solid Tumors; Status: Recruiting; Study ID: NCT01402063
Join Us On